Electrophysiologic Management and Considerations for D-transposition of the Great Arteries After Atrial Baffle Repair

Akash H Patel1, Diana Glovaci1,2, David Donaldson1,2,3

  • 1Department of Medicine, University of California Irvine Medical Center, Orange, CA, USA.

Insights

This case study details managing sudden cardiac death risk in a young woman with D-transposition of the great arteries after Mustard repair. It emphasizes electrophysiologic assessment for this complex congenital heart condition.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Background:

  • D-transposition of the great arteries (dTGA) is a complex congenital heart defect.
  • The Mustard procedure is a palliative surgical repair for dTGA, creating an intra-atrial baffle.
  • Adults with repaired dTGA face unique risks, including sudden cardiac death (SCD).

Observation:

  • A 35-year-old woman with a history of dTGA status post-Mustard atrial switch repair presented for evaluation.
  • The patient underwent comprehensive electrophysiologic assessment.
  • Risk stratification for SCD was a primary focus.

Findings:

  • Electrophysiologic studies are crucial for risk assessment in adults with repaired dTGA.
  • Identifying arrhythmic substrates and risk factors can guide management strategies.
  • This case underscores the importance of tailored electrophysiologic evaluation in this specific patient population.

Implications:

  • Proactive electrophysiologic management can mitigate SCD risk in adults with complex congenital heart disease.
  • Understanding long-term sequelae of Mustard repair is vital for patient care.
  • This case contributes to the knowledge base for managing arrhythmias in adults with D-transposition of the great arteries.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
165
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
81
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
50
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
69
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
83